Galectin Therapeutics (GALT) Net Equity Issued and Repurchased (2011 - 2025)
Galectin Therapeutics' (GALT) quarterly Net Equity Issued and Repurchased came in at $1.2 million in Q4 2025, up 36.46% quarter-over-quarter from $853000.0 in Q3 2025.
Galectin Therapeutics (GALT) Net Equity Issued and Repurchased (2011 - 2025) Analysis & Trends
Galectin Therapeutics' Net Equity Issued and Repurchased history runs 12 years deep, the most recent figure standing at $1.2 million for Q4 2025.
- On a quarterly basis, Net Equity Issued and Repurchased changed N/A year-over-year to $1.2 million in Q4 2025; TTM through Dec 2025 was $3.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $3.2 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased advanced to $1.2 million in Q4 2025 per GALT's latest filing, from $853000.0 in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $6.8 million in Q2 2021 and bottomed at -$1000.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Galectin Therapeutics | 227.21 Mn | 227.21 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.16 Mn |
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | 853,000.00 |
| Sep 30, 2025 | 853,000.00 |
| Jun 30, 2025 | 1.22 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Dec 31, 2021 | -1,000.00 |
| Dec 31, 2021 | -1,000.00 |
| Jun 30, 2021 | 6.82 Mn |
| Jun 30, 2021 | 6.82 Mn |
| Sep 30, 2020 | 44,000.00 |
| Sep 30, 2020 | 44,000.00 |
| Jun 30, 2020 | 44,000.00 |
| Jun 30, 2020 | 44,000.00 |
| Mar 31, 2020 | 219,000.00 |
| Mar 31, 2020 | 219,000.00 |
| Dec 31, 2019 | 902,000.00 |
| Dec 31, 2019 | 902,000.00 |
| Sep 30, 2019 | 163,000.00 |
| Sep 30, 2019 | 163,000.00 |